Government Information

Earl Gregg Swem Library

FDA Issues Final Guidance on the Evaluation and Labeling of Abuse-Deterrent Opioids

Categories: Advertising/Marketing,Health/Medical,Laws/Regulations

Agency press release with explanation about release of final guidance to assist the pharmaceutical industry on developing opioid drug products with abuse-deterrent properties.  Includes links to Federal Register and Guidance documents.  From the Food and Drug Administration